Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis

Trends in cancer(2023)10.1016/j.trecan.2023.03.003Source: DataRank Database

Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis is a research paper published in Trends in cancer (2023). On theSindex it has a DataRank of 0. It has been cited 217 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access217 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 25.95)OA: hybridTopics (40)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Charles Coleman ORCID,Triparna Sen ORCID,Utsav Sen ORCID

Live enrichment

PubMed:37029018 OpenAlex:https://openalex.org/W4362641156

National Cancer Institute

Grant: R01 CA258784

NIH HHS

Grant: S10 OD030463

Jazz Pharmaceuticals

Grant: unidentified

unidentified

Congressionally Directed Medical Research Programs

Jazz Pharmaceuticals

National Institutes of Health

FWCI

25.95

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.trecan.2023.03.003

publisherhttps://doi.org/10.1016/j.trecan.2023.03.003

publisherhttps://api.elsevier.com/content/article/PII:S2405803323000328?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405803323000328?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37029018

Fields of Study

Cancer, Lipids, and MetabolismFerroptosis and cancer prognosisRNA modifications and cancer03 medical and health sciences0302 clinical medicine

MeSH Terms

FerroptosisCoenzyme AFatty AcidsHumansNeoplasmsStearoyl-CoA DesaturaseFatty Acid Desaturases

Keywords

Stearoyl-CoA DesaturaseCancerCancer researchCancer cellCoenzyme AEnzymeFatty acid metabolismProgrammed cell deathFatty acidMetabolic pathwayMetabolismBiochemistryChemistryBiologyGeneApoptosisGene expressionGeneticsReductaseImmunotherapyCancer therapyNSCLCScd1FerroptosisFatty Acid DesaturasesNeoplasmsFatty AcidsHumans

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Identification of fatty acids synthesis and metabolism-related gene signature and prediction of prognostic model in hepatocellular carcinoma

10.6084/m9.figshare.25560882.v1figshare

Additional file 1 of Identification of fatty acids synthesis and metabolism-related gene signature and prediction of prognostic model in hepatocellular carcinoma

10.6084/m9.figshare.25560882figshare

Additional file 1 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26507200.v1figshare

Additional file 1 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26507200figshare

Additional file 2 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26507257.v1figshare

Additional file 2 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26507257figshare

Additional file 1 of Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells

10.6084/m9.figshare.26701192.v1figshare

Additional file 1 of Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells

10.6084/m9.figshare.26701192figshare

Additional file 12 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758036figshare

Additional file 12 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758036.v1figshare

Additional file 10 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758030.v1figshare

Additional file 11 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758033.v1figshare

Additional file 11 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758033figshare

Additional file 6 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758018figshare

Additional file 7 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758021.v1figshare

Additional file 10 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758030figshare

Additional file 9 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758027.v1figshare

Additional file 8 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758024figshare

Additional file 9 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758027figshare

Additional file 6 of Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer

10.6084/m9.figshare.26758018.v1figshare